VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog🤝Partner
Illustration for: China's CXMT Triples To $540B, Erasing Chip Rivals' Gains
Value Add VC/Pulse/IPO~$540B Market Cap

China's CXMT Triples To $540B, Erasing Chip Rivals' Gains

ChangXin Memory Technologies surged more than 500% on its Shanghai STAR Market debut to roughly $540 billion, sending SanDisk down 12%, Micron down 5% and SK Hynix down 6-8% in the same session.

By the Numbers

~$540B
Shanghai market cap
500%+
Debut pop
$8.6-9.8B
IPO raised
~8%
Global DRAM share
-12%
SanDisk reaction
TC
Trace Cohen
Early-stage VC & angel · Founder, New York Venture Partners
July 28, 2026
2 min read
ShareXLinkedInEmail

THE RUNDOWN

1

CXMT shares soared more than 500% on their Shanghai STAR Market debut, making the DRAM maker mainland China's most valuable company at roughly $540 billion, after an IPO that raised between $8.6 billion and $9.8 billion

2

SanDisk fell 12% to $1,270, Micron dropped 5% to $871 and SK Hynix ADRs fell 6-8% to $145 in the same trading session, as investors priced in new Chinese DRAM supply reaching the market

3

CXMT is the world's fourth-largest DRAM maker at roughly 8% share, behind Samsung at 36%, SK Hynix at 29% and Micron at 24%, and is leading a Chinese state project to develop domestic high-bandwidth memory

4

The selloff in SanDisk and Micron also reflects profit-taking after extraordinary 2026 run-ups -- SanDisk up roughly 505% year-to-date and Micron up roughly 223% -- with reports that Apple is already testing CXMT chips accelerating fears Chinese memory could reach top-tier Western customers

TC

The VC Read · Trace's Take

Trace Cohen

A fourth-place DRAM maker by market share debuting at a valuation bigger than Intel is the market pricing in China closing the memory gap fast, not where it stands today -- that's a much bigger bet than the current 8% share justifies on its own. Apple reportedly testing CXMT chips is the detail that should worry Micron and SK Hynix far more than the stock-price reaction did; qualification with a customer like Apple is how a state-backed challenger actually becomes a structural competitor, not just a hot IPO.

Tech IPO Tracker → AI Chip Wars →

Analysis

China's ChangXin Memory Technologies surged more than 500% on its Shanghai STAR Market debut, catapulting the DRAM maker to a market capitalization of roughly $540 billion and making it mainland China's single most valuable listed company -- ahead of Intel's own market cap -- after an IPO that raised between $8.6 billion and $9.8 billion.

The reaction in Western memory stocks was immediate and sharp: SanDisk fell 12% to $1,270, Micron dropped 5% to $871, and SK Hynix American depositary receipts declined 6-8% to $145, all in the same trading session. CXMT is currently the world's fourth-largest DRAM maker at roughly 8% global share, trailing Samsung at 36%, SK Hynix at 29% and Micron at 24% -- meaning today's debut values a company with meaningfully smaller current market share than its established Western and Korean rivals at a premium that assumes it closes that gap fast.

Some of the selloff in SanDisk and Micron reflects simple profit-taking after an extraordinary run: SanDisk is up roughly 505% year-to-date and Micron roughly 223%, both stocks that had become crowded, high-conviction bets on the AI-driven memory shortage well before CXMT's debut. But the deeper concern is structural -- CXMT is leading a Chinese state-backed push to develop domestic high-bandwidth memory production, and reports that Apple is already testing CXMT chips for potential future use have sharpened fears that Chinese memory could reach top-tier global customers faster than Western incumbents expected.

This debut is the same memory supercycle -- the one sending RAM costs sixfold higher and forcing Apple and Google to reprice consumer devices this week -- playing out from the supply side rather than the demand side. A state-backed Chinese DRAM maker able to raise nearly $10 billion and command a $540 billion valuation on its first trading day is a direct signal that global capital sees Chinese memory manufacturing capacity as a durable, investable bet rather than a temporary geopolitical anomaly.

What to watch: whether CXMT's post-debut share price holds these levels once the initial pop settles, whether Apple or other top-tier device makers confirm any production use of CXMT chips, and whether Micron, SanDisk and SK Hynix stabilize or continue sliding as investors reassess Western memory makers' competitive position against a newly public, well-capitalized Chinese rival.

ShareXLinkedInEmail

More on

SK Hynix →ChangXin Memory Technologies →Micron →

Reported by Eastern Herald · First reported by 24/7 Wall St. · Analysis by Value Add Pulse.

← Back to Pulse

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

IPO· Aug 9, 2026

What BofA's Extreme Bull Signal Means for Your Marks

Illustration for: What BofA's Extreme Bull Signal Means for Your Marks
IPO

What BofA's Extreme Bull Signal Means for Your Marks

BofA's Bull & Bear indicator hit 9.7, its highest since 2021 and above the firm's own 8.0 sell threshold — a trace's-take on what that extreme reading should change about how GPs mark portfolio companies against public comps.

IPO· Aug 8, 2026

Biotech IPOs Are Pricing Above Range Again

Illustration for: Biotech IPOs Are Pricing Above Range Again
IPO$532.5M combined

Biotech IPOs Are Pricing Above Range Again

BlossomHill and Braveheart Bio both upsized and priced above their original ranges this week, the clearest two-deal signal yet that the biotech IPO window -- closed to all but the strongest names in 2024-2025 -- is reopening.

IPO· Aug 7, 2026

BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq

Illustration for: BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq
IPO$150M IPO

BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq

BlossomHill Therapeutics priced an upsized IPO at $16 a share for $150M and began trading on Nasdaq under BLSM, more than 50% above the $100M target Pulse flagged when the company first filed.

@Trace_Cohen·t@nyvp.com